Search

COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection

As of July 2020, Medicine Invention Design, Inc. is sponsoring a small, controlled clinical trial for the COVID-19 AP TP Vaccine for ‘proof of concept.’

Amniotic Epithelial Cells

[A220183,T823] These cells are potential candidates for allogeneic cell therapy and regenerative medicine due to their potential for differentiation and multiplication.[A220183]

SLV319

It is developed for the treatment of obesity and other metabolic disorders.

Metralindole

In Russia, this drug was investigated for potential antidepressant activity.

Enrofloxacin

Enrofloxacin is approved by the FDA for its veterinary use. … Due to the identification of fluoroquinolone-resistant strains of _Campylobacter_, in September 2005, the FDA withdrew the approval of enrofloxacin for its use in water to treat flocks of poultry.

R1295

R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis.

Antipain

[A214481] Early studies investigated the potential for antipain to alter DNA damage and chromosomal aberrations in irradiated cells or those treated with chemical mutagens such as _N_-methyl-_N_'-nitro … [A214490] The binding of antipain to OPB has been used in molecular dynamic studies to identify other OPB inhibitors with more favourable pharmacodynamic and pharmacokinetic properties for potential development

Fasedienol

PH94B is being developed by Pherin Pharmaceuticals, Inc. for the treatment of social phobias (generalized anxiety disorder).

Clometocillin

PRX-07034